Clinical characteristics of dermatologic manifestations of COVID-19 infection: case series of 15 patients, review of literature, and proposed etiological classification

Potekaev N.N. ¹ , Zhukova O.V. ² , Protsenko D.N.¹ , Demina O.M.¹ , Khlystova E.A.¹ , Bogin V.³

International Journal of Dermatology

Blackwell Publishing Ltd

8

Английский

1000-1009

Опубликовано

Внешняя ссылка

10.1111/IJD.15030

59

2020

• ¹ Pirogov Russian National Research Medical University, Moscow, Russian Federation
• ² People's Friendship University of Russia, Moscow, Russian Federation
• ³ Cromos Pharma, Portland, OR, United States

azithromycin; ceftriaxone; glucocorticoid; hydroxychloroquine; adult; aged; Article; artificial ventilation; clinical article; clinical feature; computer assisted tomography; coronavirus disease 2019; coughing; disease severity; dyspnea; female; fever; human; male; medical history; middle aged; papulonecrotic cutaneous vasculitis; petechia; pneumonia; rash; skin manifestation; thrombocytopenia; urticaria; vasculitis; very elderly; weakness; Betacoronavirus; complication; Coronavirus infection; differential diagnosis; incidence; isolation and purification; pandemic; pathogenicity; Russian Federation; severity of illness index; skin; skin disease; virology; virus pneumonia; Aged; Aged, 80 and over; Betacoronavirus; Coronavirus Infections; Diagnosis, Differential; Female; Humans; Incidence; Male; Middle Aged; Moscow; Pandemics; Pneumonia, Viral; Severity of Illness Index; Skin; Skin Diseases